If you’re interested in using the Viper™ Catheter for delivering drugs, cell and gene-based therapies, hydrogels, or other agents in minimally invasive procedures, please reach out.
For those developing therapeutic agents, consider partnering with Boston TransTec to test your product’s properties and feasibility. In vivo or ex vivo testing with Viper™ can provide valuable insights and enhance your product’s marketability. Contact us today to discuss collaboration, pre-clinical, or clinical testing needs.
Improve and market your product better by ex vivo or in vivo testing:
Learn the strengths and weaknesses of your product.
Substantiate features, properties, and practical and therapeutic uses.
Establish injectability, viscosity, and other behaviors for hydrogels, polymers, and other viscous materials.
Study your product’s potential and productivity, including knowledge of its deliverability, its survivability from shear stress during the long tube passage, and its successful implantation into the target tissue (a hostile area for engraftment and viability).
The Viper™ Catheter is currently limited by United States law to investigational use and is not approved for sale or commercial use at this time.
